Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioCorRx (BICX) Assets Average (2016 - 2025)

Historic Assets Average for BioCorRx (BICX) over the last 17 years, with Q3 2025 value amounting to $7.1 million.

  • BioCorRx's Assets Average rose 116675.77% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year increase of 116675.77%. This contributed to the annual value of $387414.0 for FY2024, which is 3294.33% down from last year.
  • Latest data reveals that BioCorRx reported Assets Average of $7.1 million as of Q3 2025, which was up 116675.77% from $6.7 million recorded in Q2 2025.
  • In the past 5 years, BioCorRx's Assets Average ranged from a high of $7.1 million in Q3 2025 and a low of $353165.5 during Q1 2024
  • Its 5-year average for Assets Average is $1.7 million, with a median of $854652.0 in 2022.
  • As far as peak fluctuations go, BioCorRx's Assets Average crashed by 5761.37% in 2022, and later soared by 159375.84% in 2025.
  • Quarter analysis of 5 years shows BioCorRx's Assets Average stood at $1.2 million in 2021, then crashed by 34.07% to $792921.5 in 2022, then crashed by 41.78% to $461666.5 in 2023, then rose by 11.5% to $514755.5 in 2024, then surged by 1280.69% to $7.1 million in 2025.
  • Its last three reported values are $7.1 million in Q3 2025, $6.7 million for Q2 2025, and $3.6 million during Q1 2025.